Pharmaceutical Care for hypertensive patients provided within the Family Health Strategy in Goiânia, Goiás, Brazil

• Main Authors: Bárbara Posse Reis Martins, Aline Teixeira de Aquino, Mércia Pandolfo Provin, Dione Marçal Lima, Nathalie de Lourdes Souza Dewulf, Rita Goreti Amaral
• Format: Article
• Language: English
• Published: Universidade de São Paulo 2013-09-01
• Series: Brazilian Journal of Pharmaceutical Sciences
• Subjects: Atenção farmacêutica; Hipertensão arterial; Atenção primária à saúde
• Online Access: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502013000300023&lng=en&tlng=en

The aim of Pharmaceutical Care programs is to improve patients' quality of life, and such programs are particularly effective in the case of chronic diseases such as hypertension. The objective of this longitudinal study was to analyze a Pharmaceutical Care model for hypertensive patients receiving care within the Family Health Strategy (FHS). All patients were being seen by an FHS team affiliated to a primary healthcare unit in Goiânia, Goiás, Brazil. Fourteen patients participated in the study, with each patient receiving six home visits during the Pharmaceutical Care. Overall, 142 drug-related problems were reported, the most common concerning the ineffectiveness of treatment (33.8%). A total of 135 pharmaceutical interventions were performed, 92.6% of which involved pharmacist-patient communication, with 48.8% of these interventions being implemented. Cardiovascular risk decreased in three patients and remained unchanged in nine. In hypertensive patients with diabetes, fasting glucose levels were reduced in six out of nine cases. The Pharmaceutical Care model proposed here was effective in detecting drug-related problems and in proposing interventions to resolve or prevent these problems. Consequently, this may have contributed towards improving clinical parameters, such as fasting glucose levels and cardiovascular risk in hypertensive patients receiving care within the FHS.